Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06112795
Other study ID # 22-001884
Secondary ID NCI-2023-0046522
Status Recruiting
Phase
First received
Last updated
Start date October 5, 2022
Est. completion date March 1, 2026

Study information

Verified date October 2023
Source Mayo Clinic
Contact Jhenitza Raygoza
Phone 480-342-4360
Email Raygoza.Jhenitza@mayo.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study explores the cultural acceptability of community breast cancer risk assessment among Hispanic women in Maricopa county.


Description:

PRIMARY OBJECTIVES: I. Examine the association between perceived risk and mammography screening behavior and differences in perceived risk by patient characteristics in Hispanic women screened at Mountain Park Health Center (MPHC). II. Characterize attitudes, beliefs, and barriers towards mammography screening and cultural acceptability of BRCA models in community settings using focus group and interview data from under- and uninsured Hispanic women in Maricopa County. OUTLINE: This is an observational study. Participants attend an interview or participate in a focus group on study.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date March 1, 2026
Est. primary completion date March 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 65 Years
Eligibility Inclusion Criteria: - AIM 1: - Completed a baseline survey for the Latinas Learning about Density (LLEAD) study - Self-identify as Hispanic - Between 40-65 years of age - AIM 2: - Between the ages of 45 and 65 - Self-identify as Hispanic - Current residence in Maricopa County - Be under- (e.g. Arizona Health Care Cost Containment System) or uninsured at the time of enrollment - Can read and speak English or Spanish well enough to understand and complete the informed consent process and take part in either a focus group or individual interview Exclusion Criteria: - AIM I: - Women with a history of breast cancer - AIM 2: - Women with a history of breast cancer

Study Design


Intervention

Other:
Non-Interventional Study
Non-interventional study

Locations

Country Name City State
United States Mayo Clinic in Arizona Scottsdale Arizona

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mammography screening behavior Mammography screening behavior will be measured using two self-reported items: 1) history of ever having a mammogram, with a yes/no response and 2) history of last (most recent) mammogram" with the following response options: within the past year; at least 1, but less than 2 years ago; at least 2, but less than 5 years ago; 5 or more years ago; don't remember. Using these two items, a new variable of mammography screening behavior will be created, defined as the number of prior mammograms, categorizing responses as 0, 1 to 2, and 2+. Baseline (at enrollment)
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A

External Links